Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIMDWNASDAQ:BBLGWNASDAQ:DHAIWNASDAQ:TLSIW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMDWAinos$0.10-8.6%$0.13$0.03▼$0.37N/AN/A23,676 shs2,810 shsBBLGWBone Biologics$20.20-2.9%$41.42$3.00▼$95.04N/AN/A2,218 shs411 shsDHAIWDIH Holding US$0.01-51.1%$0.02$0.01▼$0.13N/AN/A204,648 shs57,033 shsTLSIWTriSalus Life Sciences$1.39+17.8%$1.37$0.81▼$2.24N/AN/A4,052 shs1,123 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMDWAinos-8.64%0.00%+22.71%+97.06%+54.62%BBLGWBone Biologics0.00%0.00%0.00%-54.40%+83.64%DHAIWDIH Holding US+110.94%-10.00%-33.17%-80.71%-61.32%TLSIWTriSalus Life Sciences0.00%+14.88%-7.95%+36.27%+33.65%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMDWAinosN/AN/AN/AN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AN/AN/AN/AN/AN/ATLSIWTriSalus Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMDWAinos 0.00N/AN/AN/ABBLGWBone Biologics 0.00N/AN/AN/ADHAIWDIH Holding US 0.00N/AN/AN/ATLSIWTriSalus Life Sciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMDWAinos$20.73KN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/ADHAIWDIH Holding US$64.47MN/AN/AN/AN/AN/ATLSIWTriSalus Life Sciences$29.43MN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMDWAinosN/AN/A0.00∞N/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/A0.00∞N/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/A0.00∞N/AN/AN/AN/AN/ATLSIWTriSalus Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMDWAinosN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AN/AN/ATLSIWTriSalus Life SciencesN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ADHAIWDIH Holding USN/ATLSIWTriSalus Life SciencesN/AInsider OwnershipCompanyInsider OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ADHAIWDIH Holding USN/ATLSIWTriSalus Life SciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMDWAinos40N/AN/ANot OptionableBBLGWBone Biologics2N/AN/ANot OptionableDHAIWDIH Holding USN/AN/AN/AN/ATLSIWTriSalus Life Sciences106N/AN/ANot OptionableTLSIW, AIMDW, BBLGW, and DHAIW HeadlinesRecent News About These CompaniesTriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comAnalysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)March 27, 2025 | markets.businessinsider.com4TLSI : Examining the Future: TriSalus Life Sciences's Earnings OutlookMarch 26, 2025 | benzinga.comTriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System MappingMarch 26, 2025 | finance.yahoo.comLake Street Initiates Coverage of TriSalus Life Sciences (TLSI) with Buy RecommendationFebruary 14, 2025 | msn.comTriSalus Life Sciences Announces Key Appointments to Board of DirectorsFebruary 3, 2025 | finance.yahoo.comTriSalus Life Sciences bolsters board with two new membersFebruary 3, 2025 | msn.comTriSalus Life Sciences expands board, appoints new directorsFebruary 2, 2025 | msn.comTrisalus life sciences CEO buys $50,302 in stockJanuary 30, 2025 | msn.comTrisalus life sciences director Sean Murphy buys $157,200 in stockJanuary 30, 2025 | msn.comAnalysts Are Bullish on Top Healthcare Stocks: Align Tech (ALGN), TriSalus Life Sciences (TLSI)January 24, 2025 | markets.businessinsider.comTriSalus Life Sciences sees Q4 revenue $8.3M, consensus $8.04MJanuary 23, 2025 | markets.businessinsider.comRoth expects ‘continued strong execution’ from TriSalus under new CFOJanuary 10, 2025 | markets.businessinsider.comTriSalus Life Sciences announces publication of pre-clinical dataJanuary 10, 2025 | finance.yahoo.comTriSalus Life Sciences Taps James Young as CFOJanuary 8, 2025 | marketwatch.comTriSalus Announces Leadership ChangesJanuary 8, 2025 | finance.yahoo.comTriSalus Life Sciences appoints James Young CFO, Richard Marshak CCOJanuary 8, 2025 | markets.businessinsider.comJonesTrading Remains a Buy on TriSalus Life Sciences (TLSI)January 8, 2025 | markets.businessinsider.comCantor Fitzgerald Initiates Coverage of TriSalus Life Sciences (TLSI) with Overweight RecommendationDecember 17, 2024 | msn.comTriSalus Life Sciences management to meet with MaximDecember 11, 2024 | markets.businessinsider.comMedia Sentiment Over TimeTLSIW, AIMDW, BBLGW, and DHAIW Company DescriptionsAinos NASDAQ:AIMDW$0.10 -0.01 (-8.64%) As of 04/3/2025 12:56 PM EasternAinos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Bone Biologics NASDAQ:BBLGW$20.20 -0.60 (-2.88%) As of 04/2/2025Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.DIH Holding US NASDAQ:DHAIW$0.0066 -0.01 (-51.11%) As of 12:33 PM EasternDIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider in the rehabilitation industry. The company's upper extremity product categories include ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo Senso, a sensor-based solution for arm function recovery. It also provides lower extremity product categories comprising Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, an Computer Assisted Rehabilitation Environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, the company offers M-Gait, a modular treadmill system; SafeGait, a balance and mobility trainer; and RYSEN, an 3D bodyweight supporter, as well as software products consist of D-Flow and HocoNet. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.TriSalus Life Sciences NASDAQ:TLSIW$1.39 +0.21 (+17.80%) As of 04/2/2025 03:58 PM EasternTriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Ecosystem Edge: Joby's Competitive Advantage Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Sportsman’s Warehouse Trading Volume Spike Signals Opportunity Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Arm Holdings Aims for 50% Data Center Market Share Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
